Profound Medical Corp. Announces Closing of Qualifying Transaction
June 04, 2015 17:00 ET
|
Profound Medical Inc.
TORONTO, June 4, 2015 (GLOBE NEWSWIRE) -- Profound Medical Corp. (the "Company") (TSXV:PRN), formerly Mira IV Acquisition Corp. (TSXV:MRY-P.V), announced today the completion of its qualifying...
Profound Medical Announces Going-Public Transaction and Concurrent $28 Million Financing to Fund Next Stage of Growth
April 30, 2015 19:00 ET
|
Profound Medical Inc.
TORONTO, April 30, 2015 (GLOBE NEWSWIRE) -- Profound Medical Inc. (“Profound”), a medical device company developing and commercializing a unique, minimally invasive treatment for prostate cancer,...
Profound Medical Appoints Dr. Arun Menawat to Board of Directors
October 17, 2014 07:00 ET
|
Profound Medical Inc.
TORONTO, Oct. 17, 2014 (GLOBE NEWSWIRE) -- Profound Medical Inc., a medical device company developing and commercializing a unique, minimally invasive treatment for prostate cancer, today announced...
Profound Medical Appoints Shameze Rampertab as Chief Financial Officer
October 15, 2014 07:00 ET
|
Profound Medical Inc.
TORONTO, Oct. 15, 2014 (GLOBE NEWSWIRE) -- Profound Medical Inc., a medical device company developing and commercializing a unique, minimally invasive treatment for prostate cancer, today announced it...